Erratum: Local targeting of NAD+salvage pathway alters the immune tumor microenvironment and enhances checkpoint immunotherapy in glioblastoma (Cancer Res (2020) 80 (5024-5034) DOI: 10.1158/0008-5472.CAN-20-1094)

Ming Li; Ameya R. Kirtane; Juri Kiyokawa; Hiroaki Nagashima; Aaron Lopes; Zain A. Tirmizi; Christine K. Lee; Giovanni Traverso; Daniel P. Cahill; Hiroaki Wakimoto

doi:10.1158/0008-5472.CAN-21-0525

Erratum: Local targeting of NAD⁺salvage pathway alters the immune tumor microenvironment and enhances checkpoint immunotherapy in glioblastoma (Cancer Res (2020) 80 (5024-5034) DOI: 10.1158/0008-5472.CAN-20-1094)

Ming Li, Ameya R. Kirtane, Juri Kiyokawa, Hiroaki Nagashima, Aaron Lopes, Zain A. Tirmizi, Christine K. Lee, Giovanni Traverso, Daniel P. Cahill, Hiroaki Wakimoto

Cellular Mechanisms of Cancer

Research output: Contribution to journal › Comment/debate › peer-review

1 Scopus citations

Abstract

In the original version of this article (1), the original version of Fig. 4C used two different exposures of the same field of cells to represent two different treatment conditions. The authors provided a corrected version of Fig. 4C and the error has been corrected in the latest online HTML and PDF versions of the article. The authors regret this error.

Original language	English (US)
Pages (from-to)	1922
Number of pages	1
Journal	Cancer Research
Volume	81
Issue number	7
DOIs	https://doi.org/10.1158/0008-5472.CAN-21-0525
State	Published - Apr 2021

Bibliographical note

Publisher Copyright:
© 2021 American Association for Cancer Research.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Publisher link

10.1158/0008-5472.CAN-21-0525

Find It

Find It at U of M Libraries

Fingerprint

Dive into the research topics of 'Erratum: Local targeting of NAD⁺salvage pathway alters the immune tumor microenvironment and enhances checkpoint immunotherapy in glioblastoma (Cancer Res (2020) 80 (5024-5034) DOI: 10.1158/0008-5472.CAN-20-1094)'. Together they form a unique fingerprint.

Cite this

Li, M., Kirtane, A. R., Kiyokawa, J., Nagashima, H., Lopes, A., Tirmizi, Z. A., Lee, C. K., Traverso, G., Cahill, D. P., & Wakimoto, H. (2021). Erratum: Local targeting of NAD⁺salvage pathway alters the immune tumor microenvironment and enhances checkpoint immunotherapy in glioblastoma (Cancer Res (2020) 80 (5024-5034) DOI: 10.1158/0008-5472.CAN-20-1094). Cancer Research, 81(7), 1922. https://doi.org/10.1158/0008-5472.CAN-21-0525

Erratum: Local targeting of NAD⁺salvage pathway alters the immune tumor microenvironment and enhances checkpoint immunotherapy in glioblastoma (Cancer Res (2020) 80 (5024-5034) DOI: 10.1158/0008-5472.CAN-20-1094). / Li, Ming; Kirtane, Ameya R.; Kiyokawa, Juri et al.
In: Cancer Research, Vol. 81, No. 7, 04.2021, p. 1922.

Research output: Contribution to journal › Comment/debate › peer-review

Li, M, Kirtane, AR, Kiyokawa, J, Nagashima, H, Lopes, A, Tirmizi, ZA, Lee, CK, Traverso, G, Cahill, DP & Wakimoto, H 2021, 'Erratum: Local targeting of NAD⁺salvage pathway alters the immune tumor microenvironment and enhances checkpoint immunotherapy in glioblastoma (Cancer Res (2020) 80 (5024-5034) DOI: 10.1158/0008-5472.CAN-20-1094)', Cancer Research, vol. 81, no. 7, pp. 1922. https://doi.org/10.1158/0008-5472.CAN-21-0525

@article{54ff648167734464ae4085ff3aaf2a79,

title = "Erratum: Local targeting of NAD+salvage pathway alters the immune tumor microenvironment and enhances checkpoint immunotherapy in glioblastoma (Cancer Res (2020) 80 (5024-5034) DOI: 10.1158/0008-5472.CAN-20-1094)",

abstract = "In the original version of this article (1), the original version of Fig. 4C used two different exposures of the same field of cells to represent two different treatment conditions. The authors provided a corrected version of Fig. 4C and the error has been corrected in the latest online HTML and PDF versions of the article. The authors regret this error.",

author = "Ming Li and Kirtane, {Ameya R.} and Juri Kiyokawa and Hiroaki Nagashima and Aaron Lopes and Tirmizi, {Zain A.} and Lee, {Christine K.} and Giovanni Traverso and Cahill, {Daniel P.} and Hiroaki Wakimoto",

note = "Publisher Copyright: {\textcopyright} 2021 American Association for Cancer Research.",

year = "2021",

month = apr,

doi = "10.1158/0008-5472.CAN-21-0525",

language = "English (US)",

volume = "81",

pages = "1922",

journal = "Cancer Research",

issn = "0008-5472",

publisher = "American Association for Cancer Research Inc.",

number = "7",

}

TY - JOUR

T1 - Erratum

T2 - Local targeting of NAD+salvage pathway alters the immune tumor microenvironment and enhances checkpoint immunotherapy in glioblastoma (Cancer Res (2020) 80 (5024-5034) DOI: 10.1158/0008-5472.CAN-20-1094)

AU - Li, Ming

AU - Kirtane, Ameya R.

AU - Kiyokawa, Juri

AU - Nagashima, Hiroaki

AU - Lopes, Aaron

AU - Tirmizi, Zain A.

AU - Lee, Christine K.

AU - Traverso, Giovanni

AU - Cahill, Daniel P.

AU - Wakimoto, Hiroaki

PY - 2021/4

Y1 - 2021/4

N2 - In the original version of this article (1), the original version of Fig. 4C used two different exposures of the same field of cells to represent two different treatment conditions. The authors provided a corrected version of Fig. 4C and the error has been corrected in the latest online HTML and PDF versions of the article. The authors regret this error.

AB - In the original version of this article (1), the original version of Fig. 4C used two different exposures of the same field of cells to represent two different treatment conditions. The authors provided a corrected version of Fig. 4C and the error has been corrected in the latest online HTML and PDF versions of the article. The authors regret this error.

UR - http://www.scopus.com/inward/record.url?scp=85104862096&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85104862096&partnerID=8YFLogxK

U2 - 10.1158/0008-5472.CAN-21-0525

DO - 10.1158/0008-5472.CAN-21-0525

M3 - Comment/debate

C2 - 34003791

AN - SCOPUS:85104862096

SN - 0008-5472

VL - 81

SP - 1922

JO - Cancer Research

JF - Cancer Research

IS - 7

ER -